Filter

Refine by collections

  • Advances and Future Directions in Pheochromocytoma and Paraganglioma (10)

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 10 items for :

  • Advances and Future Directions in Pheochromocytoma and Paraganglioma x
  • Refine by access: All content x
Clear All
Anne-Paule Gimenez-Roqueplo Université Paris Cité, PARCC, INSERM, Paris, France
Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France

Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed Close
,
Mercedes Robledo Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain

Search for other papers by Mercedes Robledo in
Google Scholar
PubMed Close
, and
Patricia L M Dahia Division of Hematology and Medical Oncology, Department Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas, USA
Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA

Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed Close

session dedicated to the metastatic forms of PCC and PGL was reported in a special issue of Endocrine-Related Cancer ( Dahia et al. 2020 ). Here we summarize some key insights on the genetics of these tumors published or presented over the past years

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0373
Volume/Issue:
Volume 30: Issue 4
Open access
Arthur S Tischler Department of Pathology and Laboratory Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA

Search for other papers by Arthur S Tischler in
Google Scholar
PubMed Close
and
Judith Favier Université Paris cité, Inserm UMR970 PARCC, Equipe Labellisée par la Ligue contre le cancer, Paris, France

Search for other papers by Judith Favier in
Google Scholar
PubMed Close

Experimental models including xenografts and cell lines derived from multiple human tumors provide a critical foundation for preclinical cancer research. These are complemented by mouse models engineered to develop tumors that faithfully

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0405
Volume/Issue:
Volume 30: Issue 5
Free access
Jared S Rosenblum Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States

Search for other papers by Jared S Rosenblum in
Google Scholar
PubMed Close
,
Herui Wang Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States

Search for other papers by Herui Wang in
Google Scholar
PubMed Close
,
Matthew A Nazari Eunice Kennedy Shriver National Institute of Child Health and Development, Bethesda, Maryland, United States

Search for other papers by Matthew A Nazari in
Google Scholar
PubMed Close
,
Zhengping Zhuang Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States

Search for other papers by Zhengping Zhuang in
Google Scholar
PubMed Close
, and
Karel Pacak Eunice Kennedy Shriver National Institute of Child Health and Development, Bethesda, Maryland, United States

Search for other papers by Karel Pacak in
Google Scholar
PubMed Close

fact, there are additional ongoing trials, such as one evaluating the combination of a new small molecular inhibitor of HIF-2α with everolimus and other immune-oncology agents in advanced or relapsed renal cancer and other malignancies sponsored by

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-23-0050
Volume/Issue:
Volume 30: Issue 10
Free access
Paul Benjamin Loughrey Patrick G Johnston Centre for Cancer Research, Queen’s University, Belfast, UK
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Paul Benjamin Loughrey in
Google Scholar
PubMed Close
,
Federico Roncaroli Geoffrey Jefferson Brain Research Centre, Division of Neuroscience and Experimental Psychology, School of Medicine, Manchester University, Manchester, UK

Search for other papers by Federico Roncaroli in
Google Scholar
PubMed Close
,
Estelle Healy Department of Cellular Pathology, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Estelle Healy in
Google Scholar
PubMed Close
,
Philip Weir Department of Neurosurgery, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Philip Weir in
Google Scholar
PubMed Close
,
Madhu Basetti Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK

Search for other papers by Madhu Basetti in
Google Scholar
PubMed Close
,
Ruth T Casey Department of Endocrinology, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK

Search for other papers by Ruth T Casey in
Google Scholar
PubMed Close
,
Steven J Hunter Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast Health & Social Care Trust, Belfast, UK

Search for other papers by Steven J Hunter in
Google Scholar
PubMed Close
, and
Márta Korbonits Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK

Search for other papers by Márta Korbonits in
Google Scholar
PubMed Close

reported in association with MAX variants include endometrial carcinoma, ganglioneuromas, neuroblastoma, pancreatic cancer, lung adenocarcinoma and breast cancer ( Walker et al. 2018 , Seabrook et al. 2021 ). In one study, germline MAX variants

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0157
Volume/Issue:
Volume 29: Issue 10
Open access
Susan Richter Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Susan Richter in
Google Scholar
PubMed Close
,
Timothy J Garrett Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA

Search for other papers by Timothy J Garrett in
Google Scholar
PubMed Close
,
Nicole Bechmann Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse, Dresden, Germany

Search for other papers by Nicole Bechmann in
Google Scholar
PubMed Close
,
Roderick J Clifton-Bligh Cancer Genetics Laboratory, Kolling Institute, Faculty of Medicine and Health, The University of Sydney, St Leonards, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, Australia

Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed Close
, and
Hans K Ghayee Department of Internal Medicine, Division of Endocrinology, University of Florida College of Medicine and Malcom Randall VA Medical Center, Gainesville, Florida, USA

Search for other papers by Hans K Ghayee in
Google Scholar
PubMed Close

homolog 1 and 2 ( EGLN1/2 ), kinesin family member 1B ( KIF1B ), DNA methyltransferase 3α ( DNMT3A ), and endothelial PAS domain-containing protein 1 ( EPAS1 or HIF2A ) ( Jhawar et al. 2022 ). Additionally, somatic mutations in these or other cancer

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0376
Volume/Issue:
Volume 30: Issue 6
Open access
Dahlia F Davidoff Cancer Genetics, Kolling Institute, Royal North Shore Hospital, St Leonards, New South Wales, Australia
University of Sydney, Camperdown, New South Wales, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, New South Wales, Australia

Search for other papers by Dahlia F Davidoff in
Google Scholar
PubMed Close
,
Eugénie S Lim Department of Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Department of Endocrinology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

Search for other papers by Eugénie S Lim in
Google Scholar
PubMed Close
,
Diana E Benn Cancer Genetics, Kolling Institute, Royal North Shore Hospital, St Leonards, New South Wales, Australia
University of Sydney, Camperdown, New South Wales, Australia

Search for other papers by Diana E Benn in
Google Scholar
PubMed Close
,
Yuvanaa Subramaniam Department of Endocrinology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

Search for other papers by Yuvanaa Subramaniam in
Google Scholar
PubMed Close
,
Eleanor Dorman Department of Endocrinology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

Search for other papers by Eleanor Dorman in
Google Scholar
PubMed Close
,
John R Burgess Department of Diabetes and Endocrinology, Royal Hobart Hospital, Hobart, Tasmania, Australia
School of Medicine, University of Tasmania, Hobart, Tasmania, Australia

Search for other papers by John R Burgess in
Google Scholar
PubMed Close
,
Scott A Akker Department of Endocrinology, William Harvey Research Institute, Queen Mary University of London, London, UK
Department of Endocrinology, St. Bartholomew’s Hospital, Barts Health NHS Trust, London, UK

Search for other papers by Scott A Akker in
Google Scholar
PubMed Close
, and
Roderick J Clifton-Bligh Cancer Genetics, Kolling Institute, Royal North Shore Hospital, St Leonards, New South Wales, Australia
University of Sydney, Camperdown, New South Wales, Australia
Department of Endocrinology, Royal North Shore Hospital, St Leonards, New South Wales, Australia

Search for other papers by Roderick J Clifton-Bligh in
Google Scholar
PubMed Close

tumour suppressor SIRT3 Node-positive breast cancer TNFa and TNFb Tumour necrosis Relates to neurological development ARX Non-syndromic intellectual disability and brain malformations CTDP1 Congenital cataract

Article Type:
Research Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0233
Volume/Issue:
Volume 30: Issue 5
Open access
Francesca Amore Department Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

Search for other papers by Francesca Amore in
Google Scholar
PubMed Close
,
Rachele Garella Department Experimental and Clinical Medicine, University of Florence, Florence, Italy

Search for other papers by Rachele Garella in
Google Scholar
PubMed Close
,
Alice Santi Department Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

Search for other papers by Alice Santi in
Google Scholar
PubMed Close
,
Daniele Guasti Department of Experimental and Clinical Medicine, Imaging Platform, University of Florence, Italy

Search for other papers by Daniele Guasti in
Google Scholar
PubMed Close
,
Serena Martinelli Department Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy
Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, Florence, Italy
ENS@T Center of Excellence, Florence, Italy

Search for other papers by Serena Martinelli in
Google Scholar
PubMed Close
,
Letizia Canu Department Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy
Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, Florence, Italy
ENS@T Center of Excellence, Florence, Italy

Search for other papers by Letizia Canu in
Google Scholar
PubMed Close
,
Daniele Bani Department of Experimental and Clinical Medicine, Imaging Platform, University of Florence, Italy

Search for other papers by Daniele Bani in
Google Scholar
PubMed Close
,
Jiri Neuzil Institute of Biotechnology, Czech Academy of Sciences, Prague-West, Czech Republic
School of Pharmacy and Medical Science, Griffith University, Southport, Queensland, Australia
Faculty of Science and 1st Medical Faculty, Charles University, Prague, Czech Republic

Search for other papers by Jiri Neuzil in
Google Scholar
PubMed Close
,
Mario Maggi Department Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy
Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, Florence, Italy
ENS@T Center of Excellence, Florence, Italy

Search for other papers by Mario Maggi in
Google Scholar
PubMed Close
,
Roberta Squecco Department Experimental and Clinical Medicine, University of Florence, Florence, Italy

Search for other papers by Roberta Squecco in
Google Scholar
PubMed Close
, and
Elena Rapizzi Department Experimental and Clinical Medicine, University of Florence, Florence, Italy
Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, Florence, Italy
ENS@T Center of Excellence, Florence, Italy

Search for other papers by Elena Rapizzi in
Google Scholar
PubMed Close

and differentiation. Interestingly, electrophysiological studies in several cancer cell types ( Yang & Brackenbury 2013 ) have revealed depolarized membrane potential that favours cell proliferation: cancerous cells tend to have a depolarized RMP and

Article Type:
Research Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-23-0167
Volume/Issue:
Volume 30: Issue 10
Restricted access
David Taïeb Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by David Taïeb in
Google Scholar
PubMed Close
,
Christelle Fargette Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France

Search for other papers by Christelle Fargette in
Google Scholar
PubMed Close
,
Abhishek Jha Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Abhishek Jha in
Google Scholar
PubMed Close
, and
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed Close

Determinants of molecular imaging phenotypes. Nutrient tracers Beyond glucose, there is an expanding metabolic repertoire of agents that are needed to fuel different cancers. Metabolism is influenced by many factors: cell lineage, drivers, and

Article Type:
Review Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0375
Volume/Issue:
Volume 30: Issue 4
Free access
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed Close
and
Roderick Clifton-Bligh Department of Endocrinology Royal North Shore Hospital, University of Sydney, Australia

Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed Close

. 2014 ). Soon after, the National Institutes of Health initiated the Cancer Genome Atlas beginning with 10 cancers which included pheochromocytoma and paraganglioma. This initiative included international experts on pheochromocytoma and paraganglioma

Article Type:
Editorial
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-23-0030
Volume/Issue:
Volume 30: Issue 5
Free access
Liang Zhang Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Liang Zhang in
Google Scholar
PubMed Close
,
Tobias Åkerström Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Tobias Åkerström in
Google Scholar
PubMed Close
,
Kazhan Mollazadegan Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Kazhan Mollazadegan in
Google Scholar
PubMed Close
,
Felix Beuschlein Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich (USZ) and Univeristät Zürich (UZH), Zurich, Switzerland
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany

Search for other papers by Felix Beuschlein in
Google Scholar
PubMed Close
,
Karel Pacak Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA

Search for other papers by Karel Pacak in
Google Scholar
PubMed Close
,
Britt Skogseid Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Britt Skogseid in
Google Scholar
PubMed Close
, and
Joakim Crona Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Search for other papers by Joakim Crona in
Google Scholar
PubMed Close

, Fishbein et al. 2021 ). While core needle biopsy (CNB)-based disease characterization is now facilitating individualized anti-cancer therapy strategies for many tumor entities, lacking effective therapy is the current therapeutic dilemma in metastatic

Article Type:
Research Article
Collections:
Advances and Future Directions in Pheochromocytoma and Paraganglioma
DOI:
https://doi.org/10.1530/ERC-22-0354
Volume/Issue:
Volume 30: Issue 7
Open access